Crystal structure of two CD46 domains reveals an extended measles virus-binding surface

J M Casasnovas1, M Larvie, T Stehle

  • 1Department of Biosciences at NOVUM, Karolinska Institute, 14157 Huddinge, Sweden.

The EMBO Journal
|June 5, 1999
PubMed

Insights

Researchers determined the measles virus CD46 receptor structure, revealing a novel binding mechanism. This discovery could lead to new antiviral therapies targeting measles virus entry.

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • Measles virus causes significant global morbidity and mortality.
  • CD46 serves as the human cell surface receptor for measles virus.
  • Understanding virus-receptor interactions is crucial for developing antiviral strategies.

Purpose of the Study:

  • To elucidate the crystal structure of the measles virus-binding fragment of CD46.
  • To characterize the molecular details of measles virus recognition by CD46.
  • To identify potential targets for novel antiviral agents.

Main Methods:

  • X-ray crystallography was used to determine the structure of the CD46 fragment at 3.1 A resolution.
  • Analysis of the protein structure to identify key amino acids and surface features involved in virus binding.

Main Results:

  • The crystal structure revealed the architecture of two glycosylated short consensus repeats in CD46.
  • A large, glycan-free surface involved in measles virus binding was identified, extending across both repeats.
  • A critical virus-binding epitope was located on a hydrophobic loop at the base of the first repeat.

Conclusions:

  • The CD46 structure presents a novel mode of virus recognition compared to other known viral receptors.
  • The identified virus-binding surface and epitope offer potential targets for therapeutic intervention.
  • Mimicking the conformation of the critical loop could lead to effective anti-measles virus agents.

Related Concept Videos